Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving virus or bacteriophage
Reexamination Certificate
2006-10-17
2006-10-17
Campell, Bruce R. (Department: 1648)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving virus or bacteriophage
Reexamination Certificate
active
07122302
ABSTRACT:
The present invention concerns a polypeptide which is composed of the amino acids 1207±10 to 1488±10 of a hepatitis C virus and of less than 20 foreign amino acids and the use of this polypeptide as an antigen in an immunological test.
REFERENCES:
patent: RE32696 (1988-06-01), Schuurs et al.
patent: 6306579 (2001-10-01), Seidel et al.
patent: 06-74956 (1994-03-01), None
Beach et al. Temporal relationships of hepatitis C virus RNA and antibody responses following experimental infection of chimpanzees Journal of Medical Virology 36(3):226-237, 1992.
Vallari et al., Serological markers of posttransfusion hepatitis C viral infection. Journal of clinical microbiology 30(3):552-556, 1992.
Mangold et al. “Secretion and Antigenicity of Hepatitis B Virus Small Envelope Proteins Lacking Cysteines in the Major Antigenic Region” Virol. (1995) 211, 535-543.
Mangold, C.M. “Secretion and Antigenicity of Hepatitis B Small Envelope Proteins Lacking Cysteines in the Major Antigenic Region” Virol. (1995) 211, 535-543.
Wasenauer, G. “Relevance of Cysteine Residues for Biosynthesis and Antigenicity of Human Hepatitis B Virus e Protein” J. Virol. (Mar. 1993) 67, 3, 1315-1321.
Long, D. “Cysteine Mutants of Herpes Simplex Virus Type 1 Glycoprotein D Exhibit Temperature-Sensitive Properties in Structure and Function” J. Virol. (Nov. 1990) 64, 11, 5542-5552.
Motz Manfred
Schmitt Urban
Seidel Christoph
Soutschek Erwin
Upmeier Barbara
Boesen Agnieszka
Campell Bruce R.
Fulbright & Jaworski LLP
Roche Diagnostic GmbH
LandOfFree
Method for determining early HCV seroconversion does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for determining early HCV seroconversion, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for determining early HCV seroconversion will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3652645